Eurofins Scientific SE | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Conclusion | Trade Plan Execution & Risk Management On Demand;
Overall Consensus | Sell
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.97 EUR
310.30 M EUR
6.51 B EUR
127.80 M
About EUROFINS SCIENT.
Sector
CEO
Gilles G. Martin
Website
Headquarters
Luxembourg
Founded
2012
ISIN
FR0014000MR3
FIGI
BBG00X8QFTY4
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.
Investment Opportunity ERFWe can see a clear reaction of ERF in the demand zone which initiated the previous bullish trend and broke the structure on the left side, this reaction is validated by a brake of structure in weekly timeframe, I'm expecting now the price to be bullish and potentially make new all time highs.
EUROFINS - If the Breaks and Sustains Below 332 will See 325-324EUROFINS - If the Breaks and Sustains Below 332 will See 325-324
I work here so Just analyzing
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ESF is 46.24 EUR — it has increased by 1.58% in the past 24 hours. Watch EUROFINS SCIENTIFIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange EUROFINS SCIENTIFIC stocks are traded under the ticker ESF.
ESF stock has risen by 0.74% compared to the previous week, the month change is a −6.07% fall, over the last year EUROFINS SCIENTIFIC has showed a −10.91% decrease.
We've gathered analysts' opinions on EUROFINS SCIENTIFIC future price: according to them, ESF price has a max estimate of 89.00 EUR and a min estimate of 42.00 EUR. Watch ESF chart and read a more detailed EUROFINS SCIENTIFIC stock forecast: see what analysts think of EUROFINS SCIENTIFIC and suggest that you do with its stocks.
ESF stock is 2.08% volatile and has beta coefficient of 1.05. Track EUROFINS SCIENTIFIC stock price on the chart and check out the list of the most volatile stocks — is EUROFINS SCIENTIFIC there?
Today EUROFINS SCIENTIFIC has the market capitalization of 8.78 B, it has decreased by −0.67% over the last week.
Yes, you can track EUROFINS SCIENTIFIC financials in yearly and quarterly reports right on TradingView.
EUROFINS SCIENTIFIC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
ESF earnings for the last half-year are 1.64 EUR per share, whereas the estimation was 1.48 EUR, resulting in a 10.77% surprise. The estimated earnings for the next half-year are 1.56 EUR per share. See more details about EUROFINS SCIENTIFIC earnings.
EUROFINS SCIENTIFIC revenue for the last half-year amounts to 3.42 B EUR, despite the estimated figure of 3.47 B EUR. In the next half-year revenue is expected to reach 3.60 B EUR.
ESF net income for the last half-year is 220.70 M EUR, while the previous report showed 158.80 M EUR of net income which accounts for 38.98% change. Track more EUROFINS SCIENTIFIC financial stats to get the full picture.
Yes, ESF dividends are paid annually. The last dividend per share was 0.50 EUR. As of today, Dividend Yield (TTM)% is 1.09%. Tracking EUROFINS SCIENTIFIC dividends might help you take more informed decisions.
EUROFINS SCIENTIFIC dividend yield was 0.85% in 2023, and payout ratio reached 31.09%. The year before the numbers were 1.49% and 31.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 61.80 K employees. See our rating of the largest employees — is EUROFINS SCIENTIFIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUROFINS SCIENTIFIC EBITDA is 1.34 B EUR, and current EBITDA margin is 18.59%. See more stats in EUROFINS SCIENTIFIC financial statements.
Like other stocks, ESF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUROFINS SCIENTIFIC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUROFINS SCIENTIFIC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUROFINS SCIENTIFIC stock shows the sell signal. See more of EUROFINS SCIENTIFIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.